Financhill
Back

Protara Therapeutics Quote, Financials, Valuation and Earnings

Protara Therapeutics Price Quote

$1.96

Protara Therapeutics Key Stats

Sell
35
Protara Therapeutics (TARA) is a Sell

Day range:
$1.95 - $2.02
52-week range:
$1.04 - $5.24
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.44%

Volume:
74.1K
Avg. volume:
184.5K
1-year change:
13.29%
Market cap:
$40.4M
Revenue:
$0
EPS:
$-3.19

How Much Does Protara Therapeutics Make?

Data Unavailable

Is Protara Therapeutics Growing As A Company?

Data Unavailable

Protara Therapeutics Stock Price Performance

What Is Protara Therapeutics 52-Week High & Low?

Protara Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Protara Therapeutics?

Is Protara Therapeutics Cash Flow Positive?

  • What Is TARA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$33.3M
  • What Is Protara Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $42M
  • What Is Protara Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $46.9M

Protara Therapeutics Return On Invested Capital

Data Unavailable

Protara Therapeutics Earnings Date & Stock Price

Protara Therapeutics Competitors

Protara Therapeutics Dividend Yield

Protara Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 38.98%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 26.40
Upside from Last Price: 1246.94%

Major Shareholders

  • How many TARA shares are owned by institutional investors?
    14.3M TARA shares are owned by institutional investors
  • How many TARA shares are owned by insiders?
    1.6M TARA shares are owned by insiders